Skip header and navigation

7 records – page 1 of 1.

Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight

https://policybase.cma.ca/en/permalink/policy14125
Date
2019-Sep-03
Topics
Health care and patient safety
Population health/ health equity/ public health
  1 document  

Health Canada consultation on proposed vaping products promotion regulations

https://policybase.cma.ca/en/permalink/policy14128
Date
2020-Jan-20
Topics
Health care and patient safety
Population health/ health equity/ public health
  1 document  

Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products

https://policybase.cma.ca/en/permalink/policy14022
Date
2019-Mar-22
Topics
Health care and patient safety
Population health/ health equity/ public health
  1 document  

Health Canada consultation on vaping products labelling and packaging regulations

https://policybase.cma.ca/en/permalink/policy14124
Date
2019-Sep-05
Topics
Health care and patient safety
Population health/ health equity/ public health
  1 document  

International commercial surrogacy

https://policybase.cma.ca/en/permalink/policy13702
Date
2017-Aug-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Policy Type
Policy resolution
Date
2017-Aug-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Less detail

Mandatory labelling, warnings and a recall system for prescription pharmaceuticals

https://policybase.cma.ca/en/permalink/policy13714
Date
2017-Aug-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Policy Type
Policy resolution
Date
2017-Aug-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Less detail

Nutritional guidelines in Canadian schools

https://policybase.cma.ca/en/permalink/policy13706
Date
2017-Aug-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Policy Type
Policy resolution
Date
2017-Aug-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Less detail

7 records – page 1 of 1.